Clinical Trial Update: Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating azacitidine and chimerism in patients with myelodysplastic syndrome or acute myeloid leukemia after allogeneic stem cell trans…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Azacitidine (Vidaza) (azacitidine)

Snippet

Sponsor: Henry Ford Health System | Conditions: Myeloid Malignancy | Phase 2 | Status: RECRUITING